Trial Outcomes & Findings for Ketamine Infusion and Hypoventilation (NCT NCT01535976)

NCT ID: NCT01535976

Last Updated: 2014-04-01

Results Overview

Subjects receiving intraoperative ketamine in addition to propofol will demonstrate less hypoventilation during the surgical procedure.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

54 participants

Primary outcome timeframe

8 hours

Results posted on

2014-04-01

Participant Flow

Hospital based recruitment. From August 2011 to June 2012.

Participant milestones

Participant milestones
Measure
Ketamine
Infusion of ketamine Ketamine : Ketamine infusion .5mg/kg bolus followed by 1.5 mcg/kg/minute until end of case
Placebo
.9 normal saline infusion Placebo : Placebo Comparator: Placebo .9 normal saline infusion
Overall Study
STARTED
27
27
Overall Study
COMPLETED
26
26
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Ketamine Infusion and Hypoventilation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ketamine
n=27 Participants
Infusion of ketamine Ketamine : Ketamine infusion .5mg/kg bolus followed by 1.5 mcg/kg/minute until end of case along with propofol 100 mcg/kg/min
Placebo
n=27 Participants
normal saline infusion Placebo : Placebo Comparator: Placebo normal saline infusion along with propofol 100 mcg/kg/min
Total
n=54 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
27 Participants
n=5 Participants
27 Participants
n=7 Participants
54 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
48.4 years
STANDARD_DEVIATION 7.67 • n=5 Participants
46.89 years
STANDARD_DEVIATION 7.35 • n=7 Participants
47.65 years
STANDARD_DEVIATION 7.55 • n=5 Participants
Sex: Female, Male
Female
27 Participants
n=5 Participants
27 Participants
n=7 Participants
54 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
27 participants
n=5 Participants
27 participants
n=7 Participants
54 participants
n=5 Participants

PRIMARY outcome

Timeframe: 8 hours

Population: The median percentage of the sedation time with TCO2 \> 50 mmHg

Subjects receiving intraoperative ketamine in addition to propofol will demonstrate less hypoventilation during the surgical procedure.

Outcome measures

Outcome measures
Measure
Ketamine
n=26 Participants
Infusion of ketamine Ketamine : Ketamine infusion .5mg/kg bolus followed by 1.5 mcg/kg/minute until end of case along with propofol 100 mcg/kg/min.
Placebo
n=26 Participants
normal saline infusion Placebo : Placebo Comparator: Placebo normal saline infusion along with propofol 100 mcg/kg/min
Intraoperative Hypoventilation
1.2 % time
95% Confidence Interval 95 • Interval 0.0 to 83.0
65 % time
Interval 0.0 to 88.0

Adverse Events

Ketamine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Gildasio De Oliveira MD

Northwestern University

Phone: 312-472-3573

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place